Advances in the cellular immunological pathogenesis of type 1 diabetes
Authors:
Open Access
- 14 March 2014
- journal article
- review article
- Published by Wiley in Journal of Cellular and Molecular Medicine
- Vol. 18 (5) , 749-758
Abstract
Type 1 diabetes is an autoimmune disease caused by the immune‐mediated destruction of insulin‐producing pancreatic β cells. In recent years, the incidence of type 1 diabetes continues to increase. It is supposed that genetic, environmental and immune factors participate in the damage of pancreatic β cells. Both the immune regulation and the immune response are involved in the pathogenesis of type 1 diabetes, in which cellular immunity plays a significant role. For the infiltration of CD4+ and CD8+ T lymphocyte, B lymphocytes, natural killer cells, dendritic cells and other immune cells take part in the damage of pancreatic β cells, which ultimately lead to type 1 diabetes. This review outlines the cellular immunological mechanism of type 1 diabetes, with a particular emphasis to T lymphocyte and natural killer cells, and provides the effective immune therapy in T1D, which is approached at three stages. However, future studies will be directed at searching for an effective, safe and long‐lasting strategy to enhance the regulation of a diabetogenic immune system with limited toxicity and without global immunosuppression.Keywords
This publication has 139 references indexed in Scilit:
- B7-H4.Ig inhibits the development of Type 1 diabetes by regulating Th17 cells in NOD miceCellular Immunology, 2013
- Foxp3+Regulatory T Cells in Mouse Models of Type 1 DiabetesJournal of Diabetes Research, 2013
- Structural basis for the killing of human beta cells by CD8+ T cells in type 1 diabetesNature Immunology, 2012
- A novel triple mix radiobinding assay for the three ZnT8 (ZnT8-RWQ) autoantibody variants in children with newly diagnosed diabetesJournal of Immunological Methods, 2011
- T-cell vaccination leads to suppression of intrapancreatic Th17 cells through Stat3-mediated RORγt inhibition in autoimmune diabetesCell Research, 2011
- Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunitImmunobiology, 2011
- α4β7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic miceJournal of Autoimmunity, 2010
- Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF‐β‐dependent mannerEuropean Journal of Immunology, 2009
- APC dysfunction is correlated with defective suppression of T cell proliferation in human type 1 diabetesClinical Immunology, 2009
- Dendritic cells and cytokines in human inflammatory and autoimmune diseasesCytokine & Growth Factor Reviews, 2008